CIBC Private Wealth Group’s Coya Therapeutics COYA Stock Holding History

CIBC Private Wealth Group’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$47K	Buy	+8,100	New	+$49.2K	﹤0.01%	1809

Other funds holding COYA

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CIBC Private Wealth Group's COYA Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Coya Therapeutics (COYA) in Q4 2025: 8,100 shares worth $47K. The stake represents ﹤0.01% of the portfolio and ranks #1809 among its holdings.

58 funds tracked by Wall St. Rank hold COYA as of Q4 2025.

CIBC Private Wealth Group held 8,100 shares of Coya Therapeutics worth $47K as of Q4 2025.
Coya Therapeutics was a new CIBC Private Wealth Group position in Q4 2025.
Coya Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1809 holding.
58 funds tracked by Wall St. Rank held Coya Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.